Marker Therapeutics Inc (MRKR)

[Inoviorulez]

SRPT shareholders though had to go through a reverse stock split, but management was smart. They waited until they had news.

First reverse stock split then same day released the 6MWT for DMD which caused the stock to go from 3 per share to 12 per share. Then it climbed and fell throughout the years bouncing around 20 to 30 per share. Finally made it's trajectory after FDA approval. But SRPT was pure luck.

There was dissension at the FDA. Janet wanted to approve the drug, but others wanted to reject the drug. That caused the one guy to resign from the FDA.

Anyways MRKR is in good shape. I see it with a future regardless of targeting solid tumors. It's safe and effective which can easily be used as an adjuvant treatment/maintenance treatment with anything.